Ali Faraz's most recent trade in Tenaya Therapeutics Inc was a trade of 5,720 Common Stock done at an average price of $1.3 . Disclosure was reported to the exchange on Aug. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.25 per share. | 18 Aug 2025 | 5,720 | 311,605 | - | 1.3 | 7,167 | Common Stock |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.25 per share. | 18 Aug 2025 | 4,920 | 302,792 | - | 1.3 | 6,165 | Common Stock |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.25 per share. | 18 Aug 2025 | 3,893 | 307,712 | - | 1.3 | 4,878 | Common Stock |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.44 per share. | 16 May 2025 | 3,189 | 317,325 | - | 0.4 | 1,412 | Common Stock |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 10 Mar 2025 | 5,794 | 324,461 | - | 0.5 | 3,119 | Common Stock |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 10 Mar 2025 | 3,947 | 320,514 | - | 0.5 | 2,125 | Common Stock |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 650,000 | 650,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 401,390 | 401,390 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Feb 2025 | 401,390 | 0 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 353,271 | 353,271 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Feb 2025 | 353,271 | 0 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 161,214 | 161,214 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Feb 2025 | 161,214 | 0 | - | - | Stock Option (Right to Buy) | |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 107,500 | 295,831 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 34,424 | 330,255 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 16 Aug 2024 | 5,802 | 192,277 | - | 2.9 | 16,794 | Common Stock |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 16 Aug 2024 | 3,946 | 188,331 | - | 2.9 | 11,422 | Common Stock |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 505,000 | 505,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Ali Faraz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 85,000 | 198,079 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Ali Faraz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 16 Feb 2024 | 6,358 | 113,079 | - | 5.9 | 37,258 | Common Stock |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 16 Aug 2023 | 5,563 | 119,437 | - | 3.8 | 21,195 | Common Stock |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 675,000 | 675,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 125,000 | 125,000 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 401,390 | 401,390 | - | - | Stock Option (Right to buy) |